AVI-4020 Injection

DRUG2 trials

Sponsors

Sarepta Therapeutics, Inc.

Conditions

West Nile FeverWest Nile Virus

Phase 1

An Exploratory Study of AVI-4020 in Patients With Possible Acute Neuroinvasive West Nile Virus (WNV) Disease

TerminatedNCT00091845

Sarepta Therapeutics, Inc.West Nile Fever

Start: 2004-11-30End: 2004-11-30Target: 50Updated: 2009-07-08

Pharmacokinetic Study in Cerebral Spinal Fluid After a Single Dose of AVI-4020

CompletedNCT00387283

Sarepta Therapeutics, Inc.West Nile Virus

Start: 2006-10-31End: 2009-06-30Target: 14Updated: 2009-07-08